Mon, 1 October 2012
Presented by John Rush, DVM, ACVIM Cardiology, ACVECC, Tufts University at the 34th Annual Winn Feline Foundation Symposium on Feline Health. There can be little doubt that genetic mutations contribute to many, if not all, forms of hypertrophic cardiomyopathy in the cat. However these mutations cannot explain all of the manifestations of the disease. Following a review of the commonly affected cats and the typical clinical signs, newer information and research is presented relative to diagnostic testing, dietary implications, and new drugs for treatment of feline cardiomyopathy. This presentation was originally delivered on June 28, 2012 at the 34th Annual Winn Feline Foundation Symposium on Feline Health.
Direct download: Winn_Symposium_2012_Rush_Presentation.mp3
Category:Feline Health and Research -- posted at: 10:54am PDT
Comments[0]
|
Mon, 1 October 2012
Presented by Leslie A. Lyons, PhD, University of California at Davis at the 34th Annual Winn Feline Foundation Symposium on Feline Health. The recent genetic sequencing of the cat has led to the development of a powerful new genetic resource, the cat 63K DNA array. Researchers can now focus sample collection more efficiently; extended relatves are no longer required. with sample testing on the array, 63,000 DNA markers can be assessed, delivering results in 3 weeks. Dr. Lyons presents examples of recent successes for cat traits and diseases. The presentation also covers a new study design evaluating more challenging traits, such as FIP resistance and susceptibility, and other complex consditions in the cat. The original presentation was delivered on June 28, 2012 at the 34th Annual Winn Feline Foundation Symposium on Feline Health.
Direct download: Winn_Symposium_2012_Lyons_Presentation.mp3
Category:Feline Health and Research -- posted at: 10:32am PDT
Comments[0]
|